Skip to main content
. 2024 May 9;111(5):znae070. doi: 10.1093/bjs/znae070

Table 25.

Statements pertaining to MUTYH-associated polyposis-related extra-intestinal manifestations—extended version

Statements
MAP.EIM.1 What is the appropriate surveillance strategy for extra-intestinal cancers?
No surveillance for extra-intestinal cancers is recommended for MUTYH biallelic carriers.